- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01939964
Study to Determine Effectiveness of Activation Mist on Facial Skin Wrinkles
September 7, 2013 updated by: California Allergy and Asthma Medical Group, Inc.
A Double-Blind, Randomized, Placebo-controlled Study to Compare the Efficacy and Safety of Rena ™ Activation Mist on Facial Skin Wrinkles.
To determine the effect of Activation Mist (AM) on skin wrinkles and appearance.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
This study aims to study the effects of Activation Mist ( AM) on skin wrinkles.
It contains a proprietary blend of minerals and nutritional supplements which is patented as "Liquidized Infrared Negative Ion Activation Energy".
Active ingredients include sodium bicarbonate, potassium bicarbonate, sodium carbonate, strontium carbonate, gold nanoparticles, calcium, germanium, selenium , zinc, sugar and water.
When applied to the skin , it has been shown to reduce the appearance of wrinkles by stimulation of skin fibroblasts to produce new collagen while removing aging dermis cells, facilitate the production of fibrillin proteins and protect the skin from ultraviolet rays.
Study Type
Interventional
Enrollment (Anticipated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Los Angeles, California, United States, 90025
- California Allergy and Asthma Medical Group
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
30 years to 80 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
1.Male and female subjects aged 30 to 80 years of age with significant facial wrinkles as assessed by the study physician.
Exclusion Criteria:
- Women who are pregnant or lactating.
- Subjects with skin conditions that are deemed by the investigator to interfere with the results of this study , including but not limited to: uncontrolled acne, rosacea, atopic dermatitis.
- Subjects with clinically significant cardiovascular, neurological, renal, endocrine or hematological abnormalities uncontrolled on current therapy.
- Subjects with history of skin malignancy
- Subjects with signs of recent sunburn
Use of any of the following medications, within 1 week specified of visit 1
- Systemic steroids
- Topical steroids used on the face
- Topical facial preparations including but not limited to: salicylic acid and other acne products, tacrolimus, pimecrolimus.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: QUADRUPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Activation Mist
Liquid mist preparation to be sprayed topically on wrinkle areas
|
Activation Mist topical spray
Other Names:
|
PLACEBO_COMPARATOR: Placebo
sugar pill
|
Activation Mist topical spray
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Silicone skin replica analysis
Time Frame: before and after 8 weeks of treatment
|
Silflo ™ vinyl silicone ( Cuderm Corp.) is applied to the skin areas to be studied and replicas obtained after letting it stand for 3- 5 minutes.
The replica technique takes a negative copy of the skin surface which is analyzed by optical profilometry.
Optical profilometry ( BioNet Inc.) uses light intensity to assess skin wrinkle texture by objective parameters ( e.g.
spacing, breadth, shadows, num wrinkles) This will be performed before and after 8 weeks of treatment.
|
before and after 8 weeks of treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Wrinkle Score
Time Frame: every week for 8 weeks
|
A blinded evaluation will assess wrinkle appearance and grade on a scale of 0 to 5
|
every week for 8 weeks
|
Photographic evaluation
Time Frame: weekly for 8 weeks
|
A blinded evaluator will assess photographs of wrinkles and evaluate presence or absence of improvement
|
weekly for 8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2013
Primary Completion (ANTICIPATED)
June 1, 2014
Study Completion (ANTICIPATED)
August 1, 2014
Study Registration Dates
First Submitted
September 7, 2013
First Submitted That Met QC Criteria
September 7, 2013
First Posted (ESTIMATE)
September 11, 2013
Study Record Updates
Last Update Posted (ESTIMATE)
September 11, 2013
Last Update Submitted That Met QC Criteria
September 7, 2013
Last Verified
September 1, 2013
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 0012
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Skin Wrinkles on Face and Neck Areas
-
LUTRONIC CorporationCompletedFace and Neck Wrinkles, Texture, PigmentationUnited States
-
Galderma R&DCompletedWrinkles and Folds in Lower FaceGermany
-
King Chulalongkorn Memorial HospitalCompleted
-
Cosmetique Active InternationalCompleted
-
Teoxane SAActive, not recruitingSkin Aging | Fine Lines of the Face and NeckSpain
-
Goldman, Butterwick, Fitzpatrick and GroffAcclaro CorporationNot yet recruitingFace Rejuvenation | Neck Rejuvenation
-
LEO PharmaBayerCompletedSeborrheic Dermatitis on the FaceGermany
-
Cynosure, Inc.CompletedSkin Tightening of the Mandibular and Sub-mandibular AreasUnited States
-
Ulthera, IncUniversity of Texas Southwestern Medical CenterCompletedMild to Moderate Skin Laxity on Cheek | Mild to Moderate Skin Laxity on Upper Neck | Mild to Moderate Subcutaneous Fat on Cheek | Mild to Moderate Subcutaneous Fat on Upper Neck
-
Izmir Bakircay UniversityGazi UniversityCompletedHead and Neck Cancer | Lymphedema of Face | Fibrosis; SkinTurkey
Clinical Trials on Activation Mist
-
Celleration, Inc.Withdrawn
-
Celleration, Inc.CompletedCosmetic SurgeryUnited States
-
Celleration, Inc.TerminatedWound of SkinUnited States
-
Celleration, Inc.Completed
-
Sealantis Ltd.WithdrawnColorectal Cancer | Diverticulitis Colon
-
Cardiff and Vale University Health BoardCelleration, Inc.CompletedVaricose UlcerUnited Kingdom
-
Fu Jen Catholic UniversityNot yet recruitingChronic Pulmonary DiseaseTaiwan
-
University of Campinas, BrazilRecruitingPeriodontitis | Intrabony Periodontal Defect | Periodontitis, ChronicBrazil
-
Cairo UniversityCompletedPeriodontal Regeneration, Clinical and Radiographic Results, Modified Minimal Invasive SurgeryEgypt
-
Celleration, Inc.CompletedVenous Insufficiency | Venous Reflux | Lower Extremity UlcerUnited States